- Report
- August 2026
- 193 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- August 2026
- 377 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- January 2025
- 165 Pages
Global
From €2550EUR$2,850USD£2,181GBP
- Report
- August 2025
- 190 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2025
- 195 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2025
- 185 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2025
- 191 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2025
- 185 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- January 2024
- 85 Pages
Global
From €3500EUR$4,190USD£3,098GBP
- Report
- October 2024
Global
From €3132EUR$3,500USD£2,678GBP

The Troponin Test is a type of In Vitro Diagnostics (IVD) used to detect the presence of troponin, a protein found in the heart muscle. It is used to diagnose and monitor heart conditions, such as heart attack, heart failure, and cardiac arrest. The test is typically performed using a blood sample, and results are usually available within a few hours.
The Troponin Test market is a rapidly growing segment of the IVD industry, driven by the increasing prevalence of cardiovascular diseases and the need for early diagnosis and treatment. The market is expected to benefit from the development of new technologies, such as point-of-care testing, which can provide faster and more accurate results.
Some of the major players in the Troponin Test market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Ortho Clinical Diagnostics, and Sysmex Corporation. Show Less Read more